Familial hyperaldosteronism type II (FH-II) is caused by adrenocortical hyperplasia or aldosteronoma or both and is frequently transmitted in an autosomal dominant fashion. Unlike FH type I (FI-I-I), which results from fusion of the CYP11B1 and CYP11B2 genes, hyperaldosteronism in FH-II is not glucocorticoid remediable. A large family with FH-II was used for a genome wide search and its members were evaluated by measuring the aldosterone:renin ratio. In those with an increased ratio, FH-II was confirmed by fludrocortisone suppression testing. After excluding most of the genome, genetic linkage was identified with a maximum two point lod score of 3.26 at theta =0, between FH-II in this family and the polymorphic markers D7S511, D7S517, and G...
Abstract—Primary aldosteronism (PA) is the most frequent cause of secondary hypertension, and patien...
Exciting developments in knowledge of primary aldosteronism include description of new subtypes and ...
The aldosterone-to-renin ratio (ARR) is a marker of aldosterone activity in hypertension. We examine...
Once thought rare, primary aldosteronism (PAL) is now reported to be responsible for 5–10% of hypert...
Primary aldosteronism (PAL) is caused by the autonomous over-production of aldosterone. Once thought...
There are two types of familial hyperaldosteronism: FH-I and FH-II. FH-I is caused by a hybrid CYP11...
Numerous recent reports suggest that primary aldosteronism (PAL) is much more common than previously...
Familial hyperaldosteronism type II (FH-II) is characterized by autosomal dominant inheritance and h...
Primary aldosteronism (PAL) may be as much as ten times more common than has been traditionally thou...
1. Improved approaches to screening and diagnosis have revealed primary aldosteronism (PAL) to be mu...
Background Familial hyperaldosteronism type II (FH-II) is characterized by the familial occurrence o...
Background Familial hyperaldosteronism type II is a hereditary form of primary aldosteronism not att...
Primary aldosteronism affects up to 10% of hypertensive patients and is responsible for treatment re...
Primary aldosteronism is the most common form of endocrine hypertension with a prevalence of 6% in t...
Familial hyperaldosteronism type II (FH-II) is characterized by autosomal dominant inheritance and h...
Abstract—Primary aldosteronism (PA) is the most frequent cause of secondary hypertension, and patien...
Exciting developments in knowledge of primary aldosteronism include description of new subtypes and ...
The aldosterone-to-renin ratio (ARR) is a marker of aldosterone activity in hypertension. We examine...
Once thought rare, primary aldosteronism (PAL) is now reported to be responsible for 5–10% of hypert...
Primary aldosteronism (PAL) is caused by the autonomous over-production of aldosterone. Once thought...
There are two types of familial hyperaldosteronism: FH-I and FH-II. FH-I is caused by a hybrid CYP11...
Numerous recent reports suggest that primary aldosteronism (PAL) is much more common than previously...
Familial hyperaldosteronism type II (FH-II) is characterized by autosomal dominant inheritance and h...
Primary aldosteronism (PAL) may be as much as ten times more common than has been traditionally thou...
1. Improved approaches to screening and diagnosis have revealed primary aldosteronism (PAL) to be mu...
Background Familial hyperaldosteronism type II (FH-II) is characterized by the familial occurrence o...
Background Familial hyperaldosteronism type II is a hereditary form of primary aldosteronism not att...
Primary aldosteronism affects up to 10% of hypertensive patients and is responsible for treatment re...
Primary aldosteronism is the most common form of endocrine hypertension with a prevalence of 6% in t...
Familial hyperaldosteronism type II (FH-II) is characterized by autosomal dominant inheritance and h...
Abstract—Primary aldosteronism (PA) is the most frequent cause of secondary hypertension, and patien...
Exciting developments in knowledge of primary aldosteronism include description of new subtypes and ...
The aldosterone-to-renin ratio (ARR) is a marker of aldosterone activity in hypertension. We examine...